Welcome to the new Tamingthesru
Same great content - new look - improved search
A PSA on TXA: Updated recommendations for TXA in Trauma
Tranexamic acid (TXA) is an anti-fibrinolytic that may reduce hemorrhage and improve survival in trauma. While early studies raised safety concerns, newer evidence supports its use in select patients. Join Dr. Segev as he reviews key TXA trials and highlights the updated EAST guidelines on pre-hospital and in-hospital administration.
TXA in Trauma
In this journal club recap, Dr Sarah Moulds recaps a recent meta-analysis of papers looking at the therapeutic effect of TXA in patients with severe trauma. Are their higher rates of thromboembolic complications? Is mortality improved? This article by Fouche et al attempts to answer these questions.
Grand Rounds Recap 11.17.21
Join us for our last grand rounds before Thanksgiving as Drs. Finney and Diaz discuss AKI management in the ED, Dr. Gobble discusses blunt cardiac injuries, Dr. Gawron tells the story of a young man presenting with a STEMI, and Drs. Connelly and Lane give us pointers on taking care of patients in the air.